Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-19

FDA Approved: LEVALBUTEROL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application from Mylan Pharmaceuticals Inc. for Levalbuterol, confirming the availability of a generic bronchodilator. The appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levalbuterol (Levalbuterol)

Snippet

SUPPL AP for LEVALBUTEROL (LEVALBUTEROL)